Novartis Wins FDA Approval In The U.S. To Sell Its Psoriasis Drug Cosentyx By: TalkMarkets January 22, 2015 at 19:35 PM EST The FDA has cleared Novartis' drug Cosentyx to treat patients with psoriasis. Read More >> Related Stocks: AbbVie Amgen Johnson & Johnson Novartis Ag ADR